Merck KGaA family says unreservedly behind the pharma unit


DARMSTADT, Germany: The family behind Germany's Merck KGaA said it was fully committed to the group's pharmaceuticals unit, even if cancer immunotherapy hopeful avelumab does not achieve blockbuster sales. "Pharma is one of our three pillars and we absolutely stand behind it.



from Biotech News